The Contract Research Organization (CRO) solutions space faces several challenges that impact its operations, growth, and ability to deliver high-quality services to clients. The CRO industry is highly competitive, with numerous players vying for market share. As the demand for outsourced clinical research services continues to grow, competition intensifies, leading to pricing pressures and thinner profit margins for CROs. Moreover, clinical research is subject to stringent regulatory requirements imposed by health authorities worldwide. Navigating this complex regulatory landscape requires significant expertise, resources, and compliance efforts on the part of CROs. Meanwhile, patient recruitment remains one of the most challenging aspects of clinical research. CROs must navigate patient recruitment barriers such as limited awareness, geographic dispersion, and eligibility criteria.

In the vast landscape of clinical research, PSI CRO stands as a beacon of innovation, excellence, and commitment to advancing healthcare worldwide. With a rich history spanning over three decades, PSI CRO has emerged as a global leader in providing comprehensive clinical research services to pharmaceutical, biotechnology, and medical device companies. Through its unwavering dedication to quality, integrity, and scientific rigor, PSI CRO has transformed the clinical research landscape, making significant contributions to the development of life-saving therapies and treatments.

At the heart of PSI CRO’s success lies its unwavering commitment to clinical research excellence. Founded in 1995 by Dr. Robert Reekie and Dr. Roger A. Smith, PSI CRO was established with a vision to revolutionize the way clinical trials are conducted, with a focus on delivering high-quality, cost-effective solutions to clients worldwide. Since its inception, the company has remained steadfast in its mission to advance healthcare through innovative research and development, earning a reputation as a trusted partner and industry leader.

Comprehensive Clinical Research Services

PSI CRO offers a comprehensive suite of clinical research services tailored to meet the unique needs of its clients. From early-phase development to late-phase trials and post-marketing studies, PSI CRO provides end-to-end solutions across all stages of the clinical research continuum. The company’s services encompass a wide range of therapeutic areas, including oncology, infectious diseases, neurology, and rare diseases, among others, ensuring that clients have access to the expertise and resources needed to bring their products to market successfully.

VISIONAL™ , the latest addition to PSI’s INTELIA™ platform, is a machine-learning-powered system for data-driven feasibility and enrollment forecast. It models and compares hundreds of country and site combinations, their budgets and probability of success within just a few minutes. In the end, it recommends the most optimal enrollment scenario in line with sponsor key objectives. In a nutshell, VISIONAL™ is a cloud-based module that integrates and processes feasibility data tailored to a specific protocol, taking into consideration local medical practices, available patient populations, clinical trial experience, and other variables. It collates historical enrollment rates in the given patient population from both internal and external data sources. VISIONAL™ integrates historical startup timelines across more than fifty countries where PSI operates, as well as specific site knowledge data.

Sophisticated constraint-based algorithms are then applied to these data sets to model hundreds of country- and site-specific enrollment combinations to find the ideal scenario. Within minutes, clients have access to the fastest possible patient enrollment scenario cost-effective enrollment options, optimal patient enrollment scenarios that balance out associated costs and study duration. VISIONAL™ can also be used to validate the client’s requested specifications, to estimate probability of success for the expected scenarios, and to recommend alternatives.

With a presence in over 50 countries and operations spanning six continents, PSI CRO boasts a global network of experienced professionals dedicated to delivering exceptional results. The company’s team of experts includes clinical research professionals, biostatisticians, medical writers, regulatory affairs specialists, and project managers, among others, who collaborate seamlessly to execute complex clinical trials with precision and efficiency. Moreover, PSI CRO’s local expertise allows the company to navigate regulatory landscapes, cultural nuances, and logistical challenges unique to each region, ensuring compliance and operational excellence across the globe.

Embracing Innovation and Technology:

Innovation lies at the core of PSI CRO’s approach to clinical research. The company leverages cutting-edge technologies, advanced methodologies, and data-driven insights to optimize trial design, streamline operations, and enhance patient engagement. PSI CRO’s commitment to innovation is exemplified by its adoption of adaptive trial designs, real-world evidence generation, decentralized trial approaches, and digital health solutions, among others, to drive efficiency, flexibility, and effectiveness in clinical research.

PSI CRO places a strong emphasis on quality and compliance in all aspects of its operations. The company adheres to the highest industry standards and regulatory requirements, implementing robust quality management systems and rigorous quality assurance processes to ensure the integrity, accuracy, and reliability of clinical trial data. PSI CRO’s commitment to quality is underscored by its accreditation and certifications, including ISO 9001:2015 and ISO 27001:2013, among others, demonstrating its dedication to delivering excellence in clinical research.

Beyond its commercial success, PSI CRO is deeply committed to contributing to scientific advancement and knowledge dissemination. The company actively engages in research collaborations, academic partnerships, and scientific publications, sharing insights, best practices, and learnings with the broader research community. Moreover, PSI CRO’s commitment to education and training extends to its internal team, fostering a culture of continuous learning and professional development to drive innovation and excellence in clinical research.

Driving Impactful Results

Through its relentless pursuit of excellence, PSI CRO has played a pivotal role in bringing numerous life-changing therapies and treatments to market. From groundbreaking oncology drugs to novel vaccines and medical devices, PSI CRO’s contributions to clinical research have had a profound impact on patient care and public health worldwide. The company’s track record of success is reflected in its long-standing partnerships with leading pharmaceutical and biotechnology companies, as well as its recognition as a trusted and reliable partner in the clinical research community.

As PSI CRO continues to push the boundaries of clinical research, the company remains steadfast in its commitment to advancing healthcare and improving patient outcomes. With a legacy of excellence, a global network of expertise, and a relentless drive for innovation, PSI CRO is poised to lead the way in shaping the future of clinical research and making a meaningful difference in the lives of patients around the world. As the company embarks on its next chapter of growth and innovation, one thing remains certain—PSI CRO will continue to be at the forefront of clinical research excellence, pioneering new discoveries and breakthroughs that will shape the future of healthcare for generations to come.